Erkes, D. A., Cai, W., Sanchez, I. M., Purwin, T. J., Rogers, C., Field, C. O., Berger, A. C., Hartsough, E. J., Rodeck, U., Alnemri, E. S. and Aplin, A. E. Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis. Cancer Discovery. 2019; 10(2), 254-269. doi: 10.1158/2159-8290.cd-19-0672
Read MoreFedorova, L., Mudry, P., Pilatova, K., Selingerova, I., Merhautova, J., Rehak, Z., Valik, D., Hlavackova, E., Cerna, D., Faberova, L., Mazanek, P., Pavelka, Z., Demlova, R., Sterba, J., Zdrazilova-Dubska, L. Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma. Frontiers in Oncology. 2019; 9. doi:10.3389/fonc.2019.01169
Read MoreHardin, Vreeland, Clifton, Hale, Herbert, Greene, Jackson, Berry, Nichols, Yin, Yu, Wagner, Peoples. Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine. Immunotherapy (2018) 10(5), 373–382. https://doi.org/10.2217/imt-2017-0114
Read MoreTechnology Transfer and Process Development for an Autologous Cell Therapy Against Multiple Sclerosis
Read MoreGMP-Compliant Production Dendritic Cells
Read MoreImproving Cryopreservation Yield
Read MoreCurbishley SM, Blahava M, Adams DH. Designing a dendritic cell-based therapy for primary liver cancer. MACS&more, Vol 17-1/2016
Read MorePodrazil M, Horvath R, Becht E, et al. Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. (2015). Oncotarget, 5, 17891-17904. DOI: 10.18632/oncotarget.4145
Read MoreEyrich M, et al. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells. Cytotherapy – July 2014 (Vol. 16, Issue 7, Pages 946-964, DOI: 10.1016/j.jcyt.2014.02.017).
Read More